Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 8. mars 2024 kl. 13:31 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Martin Nicklasson | – | Kjøp | 40 000 | 13,81 NOK | 8. mars 2024 | NO0010714785 | XOSL - Oslo Stock Exchange |
Vedlegg
- Attachment 240308.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, March 8, 2024 - Primary insider Martin Nicklasson, Chair of the Board of Nykode Therapeutics ASA, has today acquired 40,000 shares in Nykode Therapeutics ASA at an average price of NOK 13.81 per share. Following the transaction, Martin Nicklasson holds 92,000 shares in Nykode Therapeutics ASA.
Please see further details in the attached document.